Pfizer Inc.

NYSE:PFE

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

Location

United States

Market Cap

USD 140.94 B

Share Price

USD 24.79

Avg Daily Volume

44,965,832

Change (1 day)

-2.21%

Change (1 year)

-17.86%

Change (YTD)

-6.56%

Pfizer Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 29, 2025: 23.65%

Pfizer Inc. Operating Income Margin is 23.65% for the Trailing 12 Months (TTM) ending March 29, 2025, a 632.54% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.

Pfizer Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 3.23%, a -91.71% change year over year.
Pfizer Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending April 02, 2023 was 38.93%, a 35.95% change year over year.
Pfizer Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending April 03, 2022 was 28.64%, a 54.69% change year over year.
Pfizer Inc. Operating Income Margin for the Trailing 12 Months (TTM) ending April 04, 2021 was 18.51%, a -31.18% change year over year.